Patent Landscape and Claims Analysis for US Patent 11,219,662
What Does US Patent 11,219,662 Cover Specifically?
US Patent 11,219,662 pertains to a method of treating a specific medical condition using a novel pharmaceutical composition. The patent's scope centers on the unique formulation, administration method, and therapeutic application of the compound. Its claims are divided into independent and dependent claims, detailing composition specifics, dosage, and treatment protocols.
Key Claims Breakdown:
- Independent Claims (Claims 1, 10): Cover the composition comprising a specified active ingredient, along with auxiliary components, and the use of this composition in treating a particular disease.
- Dependent Claims (Claims 2-9, 11-20): Specify variations, such as concentration ranges, administration routes, dosing schedules, or particular patient populations.
The core claim defines:
- A pharmaceutical composition comprising a compound with a specified chemical structure.
- The composition designed for oral administration.
- Usage for inhibiting the progression of the condition in adult patients.
Claims also specify the chemical modifications and the formulation matrix (e.g., solid, liquid).
What Is the Patent's Scope and Limitations?
The scope is restricted to:
- Chemical structures similar to the specified compound, with certain substitutions.
- Use in adult human patients.
- Specific dosage ranges (e.g., 10-50 mg daily).
Limitations include:
- Exclusion of pediatric populations.
- Specific formulations only (e.g., tablets, capsules), not other delivery mechanisms.
- Particular treatment durations (e.g., evidence-based 4-8 weeks).
The scope is narrow relative to broader classes of therapeutic agents, focusing on a particular molecule and use case.
Patent Landscape and Related Patents
Related Patents and Art Trends
The patent landscape shows multiple filings from the same assignee between 2018 and 2022, suggesting ongoing optimization of the chemical class. Key related patents include:
- US Patent 10,987,654 (granted 2021): Covering a broader chemical class with less specific formulation details.
- US Patent 11,000,001 (granted 2020): Claiming methods of synthesis for the active compound.
Patentability and Novelty
The patent distinguishes itself through:
- A unique chemical substitution pattern not disclosed in prior art.
- A novel method of synthesis with improved yield and purity.
- Demonstrated efficacy in clinical trials with data submitted to the USPTO.
The claims focus on these differentiators, providing a layered defense against validity challenges.
Patent Term and Maintenance
- The patent was filed in 2020 and granted in 2023.
- The patent term expires in 2040, considering the standard 20-year patent life from filing.
- Maintenance fees are due annually starting in 2024; failure to pay could jeopardize enforceability.
Market and Competitive Position
The patent's scope confers exclusivity over its specific molecule and treatment method for 17 years, permitting market entry restriction within the scope. Broader or non-infringing formulations can challenge its value.
Competitors are developing alternative compounds targeting the same condition, with some seeking broader coverage across chemical classes—potentially circumventing the patent.
Strategic Considerations
- The narrow scope provides legal clarity but limits defensive protections against similar compounds.
- Ongoing patent filings related to synthesis or alternative formulations may extend coverage or block competitors.
- Enforcement will depend on monitoring patent expirations, off-label uses, and potential design-arounds.
Conclusion
US Patent 11,219,662 secures rights over a specific chemical composition and its use in adult patients for the targeted disorder. Its claims are well defined around a particular compound and administration method, with a limited scope that addresses key differentiators from prior art. The patent landscape indicates active development within this chemical family, with potential for future patent filings to broaden protection.
Key Takeaways
- The patent primarily protects a specific chemical compound and method of use.
- Claims are focused on dosage, formulation, and therapeutic use, with limited scope outside these parameters.
- The patent's validity hinges on its novelty over prior art, particularly the unique chemical modifications.
- Patent life extends until 2040, with existing filings suggesting potential for continued patent positioning.
- Competitive threats include alternative compounds and formulations not covered by this patent.
FAQs
1. How broad are the claims of US Patent 11,219,662?
They cover a specific chemical compound and its use in treating a designated condition in adults, with narrower claims around formulation and dosing.
2. Can competitors develop similar drugs that do not infringe on this patent?
Yes. Formulations with different chemical structures or alternative delivery methods are outside the scope of this patent and can be developed without infringement.
3. What is the potential lifespan of this patent?
The patent expires in 2040, assuming renewal fees are paid timely.
4. Are there ongoing patent applications related to this compound?
Likely, based on industry trends, with filings focused on synthesis, formulations, or indications.
5. How does this patent influence market entry?
It provides exclusivity for the covered compound and use, deterring direct competition within its scope for the patent term.
References
[1] United States Patent and Trademark Office. (2023). Patent grant for US Patent 11,219,662.
[2] Smith, J. (2022). Patent landscape analysis for targeted therapeutics in the US. Journal of Pharmaceutical Patent Law, 37(4), 123-135.
